Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F97K9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,501
Award facts
- Contract value 100% obligated
- $13,501.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $13,501.10 delivery order to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen per milliliter format. This firm fixed-price, non-set-aside contract is scheduled for completion by January 21, 2026, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. Cosentyx is a biologic immunosuppressant used to treat various autoimmune and inflammatory conditions, reflecting the pharmaceutical supply requirements of military and federal healthcare systems.
This delivery order is executed under AmerisourceBergen's parent company Cencora, Inc.'s substantially larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2031. This IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply an extensive range of pharmaceutical products, brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to military treatment facilities and federal medical institutions worldwide. The non-set-aside status of this delivery order indicates that AmerisourceBergen competed successfully against other qualified vendors in an open procurement process to fulfill this specific medical supply requirement.
Quick answers
Who was awarded contract SPE2DR26F97K9?
SPE2DR26F97K9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F97K9 worth?
The government has obligated $13,501 on SPE2DR26F97K9.
Is contract SPE2DR26F97K9 an order under another contract?
Yes. SPE2DR26F97K9 is a delivery order under SPE2DR25D3505, an indefinite delivery contract.
Was contract SPE2DR26F97K9 competed?
The extent of competition for SPE2DR26F97K9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award